
Why Nexelis is ‘changing the R&D paradigm in vaccines’
Benoit Bouche, President and CEO, Nexelis, told Lu Rahman about the company's recent acquisition and what it means for the business and the vaccine sector. Nexelis is a leading provider of assay development and advanced laboratory testing services in the infectious diseases, metabolic diseases, and oncology fields. The company –… Read More















